Intramuscular use of pmma microspheres for treating calf poliomyelitis atrophy: a case report
MedNEXT Journal of Medical and Health Sciences · 2023
DOI: 10.54448/ijn23232 ↗Kurz gefasst
Fallbericht in der Zeitschrift MedNEXT Journal of Medical and Health Sciences, 2023. Verfasst von Ana Cecília Corcini und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
One of the sequelae of poliomyelitis is muscle atrophy, which presents with decreased muscle mass, especially in the lower limbs. Besides functional treatment, it is important to consider aesthetic treatment to correct muscle asymmetry because this condition negatively affects the quality of life. Case description: In this report, we describe the case of a female patient with muscle atrophy in the left calf due to poliomyelitis sequelae who was treated with intramuscular implantation of polymethylmethacrylate (PMMA) microspheres.
Results
Obtained an increase of 7 cm in the circumference of the left calf after the end of the treatment.
Conclusion
The result obtained with the intramuscular filling was effective in treating calf muscle asymmetry.
Zitieren
APA
Corcini, A. C., Bortolozo, F., Rinaldi, M., Paschoal, Â. S., & Souza, P. D. (2023). Intramuscular use of pmma microspheres for treating calf poliomyelitis atrophy: a case report. MedNEXT Journal of Medical and Health Sciences. https://doi.org/10.54448/ijn23232
Vancouver
Corcini AC, Bortolozo F, Rinaldi M, Paschoal ÂS, Souza PD. Intramuscular use of pmma microspheres for treating calf poliomyelitis atrophy: a case report. MedNEXT Journal of Medical and Health Sciences. 2023. doi:10.54448/ijn23232
BibTeX
@article{Corcini2023,
author = {Corcini, Ana Cecília and Bortolozo, Fernanda and Rinaldi, Mariana and Paschoal, Ângela Schütz and Souza, Priscila de},
title = {Intramuscular use of pmma microspheres for treating calf poliomyelitis atrophy: a case report},
journal = {MedNEXT Journal of Medical and Health Sciences},
year = {2023},
doi = {10.54448/ijn23232}
}
EUVIMED